对衰老的弹性推动了针对阿尔茨海默病的个性化干预策略
Jackson Wezeman1, Addison Keely1, Warren Ladiges1
1Department of Comparative Medicine, School of Medicine, University of Washington, Seattle, WA, USA.
概括
延迟衰老可以防止阿尔茨海默氏症 (AD) 发病. 针对衰老途径和使用猫等动物模型可以帮助开发用于早期检测和预防策略的生物标志物.
科学领域:
- 神经科学是一个神经科学.
- 老年学是一门学科.
- 生物医学研究生物医学研究
背景情况:
- 阿尔茨海默病的发病率和死亡率仍然很高,预防和诊断的进展有限.
- 衰老是AD的主要风险因素,这表明针对衰老的干预措施可以延迟或预防AD.
- 目前的研究需要改进基本方法,包括更好的动物模型来验证生物标志物.
研究的目的:
- 探索针对衰老路径的潜力,以预防或延迟阿尔茨海默病 (AD) 神经病理学.
- 突出提高抗衰老能力的必要性,作为大脑健康和AD预防的战略.
- 强调开发用于验证非侵入性生物标志物的预测性动物模型的重要性.
主要方法:
- 关于衰老路径及其与AD的联系的概念审查.
- 讨论针对个性化预防的多种衰老途径的潜力.
- 建议利用老化物猫作为一种自发性AD类神经病理模型.
主要成果:
- 延迟衰老过程可能是预防或延迟AD发病和痴呆症的有效策略.
- 针对多个衰老途径可以增强性和个性化AD预防.
- 老龄化的猫会自发地发展出类似人类AD的神经病理,作为一个有价值的研究模型.
结论:
- 旨在延缓衰老的干预措施可能是预防阿尔茨海默病的关键策略.
- 增强对衰老的弹性对于预防大脑衰老和AD至关重要.
- 开发预测性动物模型对于验证生物标志物和推进AD预防研究至关重要.
相关概念视频
Cognitive Development During Adulthood
72
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
72
Aging
40
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
40
Alzheimer's Disease: Treatment
171
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
171
Alzheimer's Disease: Overview
456
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
456
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K


